Arcturus Therapeutics Holdings, Inc. (ARCT)
7.57
+0.55
(+7.83%)
USD |
NASDAQ |
Feb 06, 16:00
7.56
-0.01
(-0.13%)
After-Hours: 20:00
Arcturus Therapeutics Holdings EPS Diluted (Quarterly) : -0.4946 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -0.8721 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Capricor Therapeutics, Inc. | -0.5375 |
| Myomo, Inc. | -0.0869 |
| Quanterix Corp. | -0.7277 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.45M |
| Revenue (Quarterly) | 14.15M |
| Total Expenses (Quarterly) | 27.60M |
| Enterprise Value | 5.710M |
| Gross Profit Margin (Quarterly) | 94.35% |
| Profit Margin (Quarterly) | -95.02% |
| Earnings Yield | -32.54% |
| Normalized Earnings Yield | -22.67 |